MJFF Grant Supports Work Into Potential of Sigma-2 Receptors

MJFF Grant Supports Work Into Potential of Sigma-2 Receptors

315561

MJFF Grant Supports Work Into Potential of Sigma-2 Receptors

Cognition Therapeutics has received a grant from the Michael J. Fox Foundation (MJFF) for Parkinson’s Research to support preclinical work into two potential sigma-2 receptor modulators for Parkinson’s disease. The Therapeutic Pipeline Program Grant award, whose amount and duration were not specified, will help to fund studies of these receptor modulators in animal models, with work led by Cognition’s vice president of research, Mary E. Hamby, PhD. “There is a need to discover and develop novel therapeutics for…

You must be logged in to read/download the full post.